Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Exercise Pulmonary Hemodynamic Response Predicts Outcomes in Fibrotic Lung Disease.

Jose A, King CS, Shlobin OA, Brown AW, Xi Wang C, Nathan SD.

Eur Respir J. 2018 Aug 9. pii: 1801015. doi: 10.1183/13993003.01015-2018. [Epub ahead of print] No abstract available.

PMID:
30093570
2.

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry.

Baughman RP, Shlobin OA, Wells AU, Alhamad EH, Culver DA, Barney J, Cordova FC, Carmona EM, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Kouranos V, O'Hare L, Baran JM, Cal JG, Lower EE, Engel PJ, Nathan SD.

Respir Med. 2018 Jun;139:72-78. doi: 10.1016/j.rmed.2018.04.015. Epub 2018 May 5.

PMID:
29858005
3.

Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia.

King CS, Brown AW, Shlobin OA, Weir N, Libre M, Franco-Palacios D, Ahmad S, Nathan SD.

Eur Respir J. 2018 Jul 4;52(1). pii: 1800545. doi: 10.1183/13993003.00545-2018. Print 2018 Jul. No abstract available.

PMID:
29773690
4.

A 24-Year-Old Woman With Precipitous Respiratory Failure After Lung Transplantation.

Warren WA, Franco-Palacios D, King CS, Shlobin OA, Nathan SD, Katugaha SB, Mani H, Brown AW.

Chest. 2018 Mar;153(3):e53-e56. doi: 10.1016/j.chest.2017.08.020.

PMID:
29519311
5.

Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.

Elinoff JM, Agarwal R, Barnett CF, Benza RL, Cuttica MJ, Gharib AM, Gray MP, Hassoun PM, Hemnes AR, Humbert M, Kolb TM, Lahm T, Leopold JA, Mathai SC, McLaughlin VV, Preston IR, Rosenzweig EB, Shlobin OA, Steen VD, Zamanian RT, Solomon MA.

Am J Respir Crit Care Med. 2018 Jul 15;198(2):166-174. doi: 10.1164/rccm.201710-2093PP. No abstract available.

PMID:
29425462
6.

Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far.

Baughman RP, Shlobin OA.

Eur Respir J. 2017 Oct 19;50(4). pii: 1701725. doi: 10.1183/13993003.01725-2017. Print 2017 Oct. No abstract available.

PMID:
29051277
7.

Sarcoidosis-Associated Pulmonary Hypertension.

Shlobin OA, Baughman RP.

Semin Respir Crit Care Med. 2017 Aug;38(4):450-462. doi: 10.1055/s-0037-1603767. Epub 2017 Jul 27. No abstract available.

PMID:
28750460
8.

Ventricular Diastolic Pressure Ratio as a Marker of Treatment Response in Pulmonary Hypertension.

Jose A, King CS, Shlobin OA, Kiernan JM, Cossa NA, Brown AW, Nathan SD.

Chest. 2017 Nov;152(5):980-989. doi: 10.1016/j.chest.2017.05.008. Epub 2017 May 17.

PMID:
28527879
9.

Early postoperative management after lung transplantation: Results of an international survey.

King CS, Valentine V, Cattamanchi A, Franco-Palacios D, Shlobin OA, Brown AW, Singh R, Bogar L, Nathan SD.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12985. Epub 2017 May 29.

PMID:
28425132
10.

Hemothorax following lung transplantation: incidence, risk factors, and effect on morbidity and mortality.

Hong A, King CS, Brown AW, Ahmad S, Shlobin OA, Khandhar S, Bogar L, Rongione A, Nathan SD.

Multidiscip Respir Med. 2016 Nov 15;11:40. eCollection 2016.

11.

Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases.

Shlobin OA, Brown AW, Nathan SD.

Chest. 2017 Jan;151(1):204-214. doi: 10.1016/j.chest.2016.08.002. Epub 2016 Aug 20. Review.

PMID:
27554299
12.

Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis.

Shin S, King CS, Puri N, Shlobin OA, Brown AW, Ahmad S, Weir NA, Nathan SD.

Eur Respir J. 2016 May;47(5):1445-51. doi: 10.1183/13993003.01532-2015. Epub 2016 Feb 4.

13.

Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease.

Shin S, King CS, Brown AW, Albano MC, Atkins M, Sheridan MJ, Ahmad S, Newton KM, Weir N, Shlobin OA, Nathan SD.

Respir Med. 2014 Nov;108(11):1626-32. doi: 10.1016/j.rmed.2014.08.009. Epub 2014 Sep 2.

14.

Outcomes after hospitalization in idiopathic pulmonary fibrosis: a cohort study.

Brown AW, Fischer CP, Shlobin OA, Buhr RG, Ahmad S, Weir NA, Nathan SD.

Chest. 2015 Jan;147(1):173-179. doi: 10.1378/chest.13-2424.

PMID:
25188694
15.

Management of right heart failure in the critically ill.

King C, May CW, Williams J, Shlobin OA.

Crit Care Clin. 2014 Jul;30(3):475-98. doi: 10.1016/j.ccc.2014.03.003. Review.

PMID:
24996606
16.

The influence of alternative instruction on 6-min walk test distance.

Weir NA, Brown AW, Shlobin OA, Smith MA, Reffett T, Battle E, Ahmad S, Nathan SD.

Chest. 2013 Dec;144(6):1900-1905. doi: 10.1378/chest.13-0287.

PMID:
23975232
17.

The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosis.

Nathan SD, Reffett T, Brown AW, Fischer CP, Shlobin OA, Ahmad S, Weir N, Sheridan MJ.

Chest. 2013 Jun;143(6):1692-1698. doi: 10.1378/chest.12-1368.

PMID:
23238641
18.

Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations.

Shlobin OA, Brown AW, Weir N, Ahmad S, Lemma M, Nathan SD.

Lung. 2012 Oct;190(5):573-8. Epub 2012 Jul 15.

PMID:
22797830
19.

Dynamic patient counseling: a novel concept in idiopathic pulmonary fibrosis.

Brown AW, Shlobin OA, Weir N, Albano MC, Ahmad S, Smith M, Leslie K, Nathan SD.

Chest. 2012 Oct;142(4):1005-1010. doi: 10.1378/chest.12-0298.

PMID:
22797563
20.

Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation.

Shlobin OA, Nathan SD.

Eur Respir J. 2012 Jun;39(6):1520-33. doi: 10.1183/09031936.00175511. Epub 2012 Jan 12. Review.

21.

Lung size mismatch in bilateral lung transplantation is associated with allograft function and bronchiolitis obliterans syndrome.

Eberlein M, Permutt S, Chahla MF, Bolukbas S, Nathan SD, Shlobin OA, Shelhamer JH, Reed RM, Pearse DB, Orens JB, Brower RG.

Chest. 2012 Feb;141(2):451-460. doi: 10.1378/chest.11-0767. Epub 2011 Jul 28.

22.

Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium.

Nathan SD, Shlobin OA, Weir N, Ahmad S, Kaldjob JM, Battle E, Sheridan MJ, du Bois RM.

Chest. 2011 Jul;140(1):221-229. doi: 10.1378/chest.10-2572. Review.

PMID:
21729893
23.

Pulmonary hypertension secondary to interstitial lung disease.

Shlobin OA, Nathan SD.

Expert Rev Respir Med. 2011 Apr;5(2):179-89. doi: 10.1586/ers.11.11. Review.

PMID:
21510729
24.

Pulmonary complications of lung transplantation.

Ahmad S, Shlobin OA, Nathan SD.

Chest. 2011 Feb;139(2):402-411. doi: 10.1378/chest.10-1048. Review.

PMID:
21285054
25.

The value of computed tomography scanning for the detection of coronary artery disease in patients with idiopathic pulmonary fibrosis.

Nathan SD, Weir N, Shlobin OA, Urban BA, Curry CA, Basavaraj A, Ahmad S, Kiernan J, Sheridan MJ, Earls JP.

Respirology. 2011 Apr;16(3):481-6. doi: 10.1111/j.1440-1843.2010.01919.x.

PMID:
21199161
26.

Idiopathic non-specific interstitial pneumonitis responsive to transplant-associated immunosuppression.

Woodrow JP, Nathan SD, Shlobin OA.

J Heart Lung Transplant. 2011 Mar;30(3):358-9. doi: 10.1016/j.healun.2010.10.019. Epub 2010 Dec 23. No abstract available.

PMID:
21185203
27.

Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis.

Swigris JJ, Olson AL, Shlobin OA, Ahmad S, Brown KK, Nathan SD.

Respirology. 2011 Apr;16(3):439-45. doi: 10.1111/j.1440-1843.2010.01877.x.

28.

Comparison of wait times and mortality for idiopathic pulmonary fibrosis patients listed for single or bilateral lung transplantation.

Nathan SD, Shlobin OA, Ahmad S, Burton NA, Barnett SD, Edwards E.

J Heart Lung Transplant. 2010 Oct;29(10):1165-71. doi: 10.1016/j.healun.2010.05.014. Epub 2010 Jul 3.

PMID:
20598580
29.

Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.

Woodrow JP, Shlobin OA, Barnett SD, Burton N, Nathan SD.

J Heart Lung Transplant. 2010 Oct;29(10):1159-64. doi: 10.1016/j.healun.2010.05.012. Epub 2010 Jun 26.

PMID:
20580267
30.

Categorization and impact of pulmonary hypertension in patients with advanced COPD.

Cuttica MJ, Kalhan R, Shlobin OA, Ahmad S, Gladwin M, Machado RF, Barnett SD, Nathan SD.

Respir Med. 2010 Dec;104(12):1877-82. doi: 10.1016/j.rmed.2010.05.009. Epub 2010 Jun 14.

31.

Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis.

Emblom-Callahan MC, Chhina MK, Shlobin OA, Ahmad S, Reese ES, Iyer EP, Cox DN, Brenner R, Burton NA, Grant GM, Nathan SD.

Genomics. 2010 Sep;96(3):134-45. doi: 10.1016/j.ygeno.2010.04.005. Epub 2010 May 6.

32.

Epstein-Barr virus-associated uterine leiomyosarcoma in an adult lung transplant patient.

Sunde J, Chetty-John S, Shlobin OA, Boice CR.

Obstet Gynecol. 2010 Feb;115(2 Pt 2):434-6. doi: 10.1097/AOG.0b013e3181c51ed0.

PMID:
20093871
33.

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis.

Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, Burton N, Barnett SD.

Respir Med. 2010 Jul;104(7):1035-41. doi: 10.1016/j.rmed.2010.02.008. Epub 2010 Mar 2.

34.

Prognostic value of the 6min walk test in bronchiolitis obliterans syndrome.

Nathan SD, Shlobin OA, Reese E, Ahmad S, Fregoso M, Athale C, Barnett SD.

Respir Med. 2009 Dec;103(12):1816-21. doi: 10.1016/j.rmed.2009.07.011. Epub 2009 Aug 13.

35.

Native lung complications in single-lung transplant recipients and the role of pneumonectomy.

King CS, Khandhar S, Burton N, Shlobin OA, Ahmad S, Lefrak E, Barnett SD, Nathan SD.

J Heart Lung Transplant. 2009 Aug;28(8):851-6. doi: 10.1016/j.healun.2009.04.023.

PMID:
19632585
36.

Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience.

Barnett CF, Bonura EJ, Nathan SD, Ahmad S, Shlobin OA, Osei K, Zaiman AL, Hassoun PM, Moller DR, Barnett SD, Girgis RE.

Chest. 2009 Jun;135(6):1455-1461. doi: 10.1378/chest.08-1881. Epub 2008 Dec 31.

37.

Potential of imatinib mesylate as a novel treatment for pulmonary fibrosis.

Chhina M, Shlobin OA, Grant G, Nathan SD.

Expert Rev Respir Med. 2008 Aug;2(4):419-31. doi: 10.1586/17476348.2.4.419.

PMID:
20477206
38.

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis.

Nathan SD, Shlobin OA, Barnett SD, Saggar R, Belperio JA, Ross DJ, Ahmad S, Saggar R, Libre E, Lynch JP 3rd, Zisman DA.

Respir Med. 2008 Sep;102(9):1305-10. doi: 10.1016/j.rmed.2008.03.022. Epub 2008 Jul 10.

39.

Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation.

Nathan SD, Shlobin OA, Ahmad S, Barnett SD, Burton NA, Gladwin MT, Machado RF.

Am J Transplant. 2008 Jul;8(7):1506-11. doi: 10.1111/j.1600-6143.2008.02277.x.

40.

Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis.

Nathan SD, Shlobin OA, Ahmad S, Koch J, Barnett SD, Ad N, Burton N, Leslie K.

Respiration. 2008;76(3):288-94. doi: 10.1159/000114246. Epub 2008 Jan 24.

PMID:
18216461
41.

Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Zisman DA, Karlamangla AS, Kawut SM, Shlobin OA, Saggar R, Ross DJ, Schwarz MI, Belperio JA, Ardehali A, Lynch JP 3rd, Nathan SD.

Chest. 2008 Mar;133(3):640-5. doi: 10.1378/chest.07-2488. Epub 2008 Jan 15.

42.

Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis.

Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD.

Chest. 2007 Mar;131(3):657-663. doi: 10.1378/chest.06-2485.

PMID:
17356077
43.

Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients.

Shlobin OA, West EE, Lechtzin N, Miller SM, Borja M, Orens JB, Dropulic LK, McDyer JF.

J Immunol. 2006 Feb 15;176(4):2625-34.

44.

Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.

Shlobin OA, Dropulic LK, Orens JB, Mcdyer JF, Conte JV, Yang SY, Girgis R.

J Heart Lung Transplant. 2005 Nov;24(11):1991-4. Epub 2005 Jun 4.

PMID:
16297812
45.

Utility of daily routine portable chest radiographs in mechanically ventilated patients in the medical ICU.

Krivopal M, Shlobin OA, Schwartzstein RM.

Chest. 2003 May;123(5):1607-14.

PMID:
12740281

Supplemental Content

Loading ...
Support Center